Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals after the Initiation of HBV‐Active Antiretroviral Therapy

Abstract
BackgroundThe pathogenesis of and risk factors for hepatic flare (HF) after the initiation of hepatitis B virus (HBV)–active antiretroviral therapy (

This publication has 0 references indexed in Scilit: